VITALE, PIETRO
 Distribuzione geografica
Continente #
AS - Asia 49
EU - Europa 44
NA - Nord America 22
SA - Sud America 6
Totale 121
Nazione #
SG - Singapore 30
US - Stati Uniti d'America 17
IT - Italia 14
HK - Hong Kong 10
RU - Federazione Russa 8
DE - Germania 7
CN - Cina 6
NL - Olanda 5
AT - Austria 4
BR - Brasile 4
CA - Canada 4
FI - Finlandia 4
AR - Argentina 2
ID - Indonesia 2
FR - Francia 1
IE - Irlanda 1
MX - Messico 1
PH - Filippine 1
Totale 121
Città #
Singapore 16
Hong Kong 10
Rome 8
Toronto 4
Lappeenranta 3
Ashburn 2
Beijing 2
Berlin 2
Buenos Aires 2
Jakarta 2
Munich 2
New York 2
Xi'an 2
Dublin 1
Frankfurt am Main 1
Genoa 1
Helsinki 1
Krasnoyarsk 1
Los Angeles 1
Manila 1
Mexico City 1
Moscow 1
Nuremberg 1
Pires do Rio 1
Raul Soares 1
Santa Clara 1
Santo Antônio de Posse 1
Senhor do Bonfim 1
Shanghai 1
Vienna 1
Totale 74
Nome #
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study) 41
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study 31
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves 31
Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature 30
Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections 8
Totale 141
Categoria #
all - tutte 1.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.973


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202437 0 0 0 13 1 2 1 5 4 0 9 2
2024/2025104 5 10 22 10 4 13 7 13 17 3 0 0
Totale 141